Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis

被引:0
作者
Anna Lepistö
Sari Kivistö
Leena Kivisaari
Johanna Arola
Heikki J. Järvinen
机构
[1] Helsinki University Central Hospital,Department of Surgery
[2] Helsinki Medical Imaging Center,Department of Pathology
[3] HUSLAB and University of Helsinki,undefined
来源
International Journal of Colorectal Disease | 2009年 / 24卷
关键词
Primary sclerosing cholangitis; Ulcerative colitis; Restorative proctocolectomy; Cholangiocarcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1169 / 1174
页数:5
相关论文
共 149 条
[1]  
Fausa O(1991)Relationship of inflammatory bowel disease and primary sclerosing cholangitis Semin Liv Dis 11 31-39
[2]  
Schrumf E(1987)Primary sclerosing cholangitis: long-term follow-up Scand J Gastroenterol 22 655-664
[3]  
Elgjo K(1980)Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology Gut 21 870-877
[4]  
Aadland E(1987)Improved survival with primary sclerosing cholangitis. A review of clinicopathological features and comparison of symptomatic and asymptomatic patients Gastroenterology 92 1869-1875
[5]  
Schrumf E(2008)Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis Inflamm Bowel Dis 14 775-779
[6]  
Fausa O(1999)Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma Ann Oncol 10 89-93
[7]  
Elgjo K(1992)Primary sclerosing cholangitis: refinement and validation of survival models Gastroenterology 103 1893-1901
[8]  
Heilo A(2007)Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures J Hepatol 47 677-678
[9]  
Aakhus T(1996)Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas Int J Cancer 66 326-331
[10]  
Gjone E(2005)High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study Gastroenterology 129 1464-1472